UNITED THERAPEUTICS CORP (UTHR)

US91307C1027 - Common Stock

243.27  -4.59 (-1.85%)

After market: 243.27 0 (0%)

News Image
2 days ago - Chartmill

Top movers in Tuesday's after hours session

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

News Image
3 days ago - InvestorPlace

The Bargain Hunter’s Portfolio: 7 Smart Stock Buys for the Shrewd Investor

Although several companies have seen their valuations blossom, you can still find bargain stocks if you know where to look.

News Image
15 days ago - InvestorPlace

The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024

Learn about these undervalued NASDAQ stocks teeming with the potential to bounce back and show great returns for investors this year.

News Image
23 days ago - InvestorPlace

Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making

These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.

News Image
a month ago - InvestorPlace

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.

News Image
2 months ago - Market News Video

United Therapeutics is Now Oversold (UTHR)

News Image
2 months ago - InvestorPlace

Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January

These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.

News Image
2 months ago - InvestorPlace

Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market

In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.

News Image
3 months ago - Seeking Alpha

MannKind, Sagard Healthcare enter $200M royalty purchase deal (NASDAQ:MNKD)

MannKind (MNKD) sells a 1% royalty in Tyvaso DPI net sales to Sagard Healthcare for up to $200M, receiving an upfront payment of $150M.

News Image
3 months ago - Seeking Alpha

Liquidia jumps on win in patent case against United Therapeutics (NASDAQ:LQDA)

Liquidia stock jumps 36% after winning a patent dispute against United Therapeutics, causing the latter stock to drop 4%.

News Image
4 months ago - Market News Video

Notable Friday Option Activity: UTHR, CZR, RIVN

News Image
4 months ago - Seeking Alpha

United Therapeutics, Eli Lilly extend licensing deal for Adcirca to 2026 (NASDAQ:UTHR)

United Therapeutics (UTHR) has extended the licensing deal with Eli Lilly (LLY) for Adcirca (tadalafil) through December 31, 2026. The deal covering the U.S. ma

News Image
4 months ago - Market News Video

Notable Friday Option Activity: UTHR, IRBT, SAVA

News Image
5 months ago - InvestorPlace

7 Healthcare Stocks That Are Poised to Become the Next Unicorns

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

News Image
5 months ago - InvestorPlace

Flying Car Stocks: What a Devastating Short Report Means for EHang

Hindenburg raised red flags for flying car stocks after releasing a short report on EH stock. Here's what investors should watch.

News Image
5 months ago - InvestorPlace

EH Stock Alert: Hindenburg Slams EHang in New Short Report

EH stock is falling back to earth after Hindenburg Research issued a short report on the electric vertical take-off and landing (eVTOL) firm.